NEWS SUMMARY: FCC. Markets kick off second half of August with drops Although no definitive peace agreement was expected to come from the talks between the US and the Ukraine-Europe delegation, stock markets took the opportunity for profit taking while rewarding defence companies in view of the possible “security guarantee” the US would offer Ukraine. In the STOXX 600, the sectors falling the most were Basic Materials and Autos, with Pharma (driven by Novo Nordisk) and Media rising the most. On...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FCC Las bolsas empiezan la segunda quincena con caídas Aunque no se esperaba un acuerdo definitivo de Paz en las conversaciones entre EE.UU. y la delegación ucraniana-europea las bolsas aprovecharon para recoger beneficios mientras que premiaba a las empresas de defensa ante la posible “garantía de seguridad” que ofrecería Estados Unidos a Ucrania. En el STOXX 600 los sectores que más cayeron fueron R. Básicos y Autos frente a Farma (impulsada por N...
NEWS SUMMARY: CELLNEX, NATURGY. Stock markets pause for a break European stock markets recovered after the strong corrections seen last Friday, fuelled by banks. Thus, in the STOXX 600 most sectors (16/20) ended with gains, led by Banks and Insurance vs. Pharma and Retail that were the worst performers. On the macro side, in the euro zone, August’s Sentix dropped significantly as opposed to expectations following the tariff agreement signed with the US to the worst level since April. In the US,...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, NATURGY. EUROPA: DHL GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Respiro en las bolsas Las bolsas europeas se recuperaron de las fuertes caídas del viernes pasado y rebotaron con el impulso de los bancos. Así, en el STOXX ...
2Q'25 vs. 2Q'24 Results Sales: € 2.375 Bn (+15.8% vs. +18.1% BS(e)); EBITDA: € 350.9 M (+38.7% vs. +43.4% BS(e)); 1H'25 vs. 1H'24 Results Sales: € 4.557 Bn (+7.5% vs. +8.7% BS(e)); EBITDA: € 675.3 M (+11.0% vs. +13.0% BS(e)); EBIT: € 254.5 M (-28.3% vs. +2.6% BS(e)); Net Profit: € 80.7 M (-71.1% vs. -52.0% BS(e));
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.